Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Work Schedule Tolerance | 55 | 2023 | 565 | 10.560 |
Why?
|
Melatonin | 41 | 2024 | 721 | 7.560 |
Why?
|
Nurses | 39 | 2023 | 2461 | 5.640 |
Why?
|
Circadian Rhythm | 45 | 2024 | 2624 | 4.680 |
Why?
|
Sleep | 30 | 2024 | 4623 | 2.380 |
Why?
|
Austria | 20 | 2023 | 203 | 2.070 |
Why?
|
Breast Neoplasms | 43 | 2023 | 20822 | 1.880 |
Why?
|
Occupational Diseases | 11 | 2023 | 1471 | 1.760 |
Why?
|
Sleep Initiation and Maintenance Disorders | 8 | 2023 | 1004 | 1.530 |
Why?
|
Lighting | 8 | 2023 | 231 | 1.410 |
Why?
|
Light | 8 | 2015 | 1374 | 1.390 |
Why?
|
Photoperiod | 2 | 2020 | 136 | 1.310 |
Why?
|
Risk Factors | 113 | 2023 | 72290 | 1.260 |
Why?
|
Life Style | 15 | 2023 | 3835 | 1.160 |
Why?
|
Urinary Bladder Neoplasms | 6 | 2023 | 2245 | 1.150 |
Why?
|
Folic Acid | 6 | 2014 | 1300 | 1.120 |
Why?
|
Depression | 12 | 2024 | 7766 | 1.120 |
Why?
|
Parkinson Disease | 14 | 2015 | 2775 | 1.070 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 8 | 2015 | 424 | 1.060 |
Why?
|
Pineal Gland | 3 | 2023 | 166 | 1.020 |
Why?
|
Female | 195 | 2024 | 380194 | 1.010 |
Why?
|
Prospective Studies | 72 | 2023 | 53288 | 1.010 |
Why?
|
Vitamin B 6 | 4 | 2014 | 237 | 0.990 |
Why?
|
Colorectal Neoplasms | 20 | 2023 | 6773 | 0.960 |
Why?
|
Menopause | 5 | 2020 | 1626 | 0.940 |
Why?
|
Mothers | 6 | 2022 | 2165 | 0.930 |
Why?
|
Occupational Exposure | 10 | 2023 | 1796 | 0.930 |
Why?
|
Chronobiology Disorders | 4 | 2019 | 74 | 0.920 |
Why?
|
Reproductive History | 2 | 2020 | 209 | 0.910 |
Why?
|
Humans | 258 | 2024 | 744343 | 0.910 |
Why?
|
Veterinarians | 1 | 2023 | 13 | 0.900 |
Why?
|
Adult | 129 | 2023 | 214055 | 0.900 |
Why?
|
Middle Aged | 137 | 2024 | 213383 | 0.860 |
Why?
|
Premenopause | 7 | 2013 | 1033 | 0.820 |
Why?
|
Trust | 2 | 2023 | 505 | 0.820 |
Why?
|
Proportional Hazards Models | 26 | 2022 | 12354 | 0.800 |
Why?
|
Occupational Health | 7 | 2016 | 809 | 0.800 |
Why?
|
Insulin-Like Growth Factor I | 8 | 2015 | 2015 | 0.790 |
Why?
|
Rhinitis, Allergic, Seasonal | 2 | 2020 | 99 | 0.770 |
Why?
|
Hormones | 3 | 2020 | 889 | 0.770 |
Why?
|
Hair Dyes | 1 | 2020 | 30 | 0.760 |
Why?
|
Body Size | 3 | 2015 | 461 | 0.740 |
Why?
|
Suicide | 4 | 2023 | 1477 | 0.740 |
Why?
|
Ownership | 1 | 2022 | 332 | 0.720 |
Why?
|
Wakefulness | 4 | 2017 | 1245 | 0.720 |
Why?
|
Pandemics | 7 | 2023 | 8388 | 0.720 |
Why?
|
Strigiformes | 1 | 2019 | 2 | 0.710 |
Why?
|
Passeriformes | 1 | 2019 | 4 | 0.710 |
Why?
|
Time Factors | 32 | 2020 | 40075 | 0.710 |
Why?
|
Diet | 9 | 2021 | 7939 | 0.710 |
Why?
|
Odds Ratio | 26 | 2020 | 9849 | 0.700 |
Why?
|
Seasons | 3 | 2021 | 1493 | 0.680 |
Why?
|
Butyrates | 1 | 2019 | 163 | 0.670 |
Why?
|
Sleep Stages | 1 | 2023 | 686 | 0.660 |
Why?
|
Prenatal Exposure Delayed Effects | 3 | 2020 | 2408 | 0.660 |
Why?
|
Neoplasms | 21 | 2024 | 21683 | 0.660 |
Why?
|
Postmenopause | 8 | 2019 | 2461 | 0.660 |
Why?
|
Adult Children | 1 | 2019 | 100 | 0.650 |
Why?
|
Cardiovascular Diseases | 12 | 2021 | 15165 | 0.640 |
Why?
|
Cohort Studies | 44 | 2023 | 40561 | 0.630 |
Why?
|
Coronavirus | 1 | 2020 | 158 | 0.620 |
Why?
|
Long Interspersed Nucleotide Elements | 5 | 2012 | 338 | 0.620 |
Why?
|
Vitamin B 12 | 3 | 2014 | 527 | 0.620 |
Why?
|
Efficiency | 1 | 2021 | 462 | 0.620 |
Why?
|
Dietary Sucrose | 2 | 2012 | 246 | 0.600 |
Why?
|
Smoking | 10 | 2023 | 8987 | 0.590 |
Why?
|
Obesity | 14 | 2024 | 12745 | 0.590 |
Why?
|
Sleep Disorders, Circadian Rhythm | 4 | 2021 | 222 | 0.590 |
Why?
|
Receptor, Melatonin, MT1 | 1 | 2016 | 30 | 0.580 |
Why?
|
Carcinoma, Basal Cell | 3 | 2020 | 545 | 0.570 |
Why?
|
Cognition | 8 | 2023 | 6770 | 0.560 |
Why?
|
Uncertainty | 2 | 2021 | 734 | 0.560 |
Why?
|
Case-Control Studies | 28 | 2020 | 21746 | 0.560 |
Why?
|
Alcohol Drinking | 6 | 2018 | 3966 | 0.550 |
Why?
|
Insulin-Like Growth Factor II | 3 | 2014 | 271 | 0.550 |
Why?
|
Hypertension | 9 | 2023 | 8480 | 0.550 |
Why?
|
Vitamin B Complex | 2 | 2008 | 288 | 0.550 |
Why?
|
Proton Pump Inhibitors | 2 | 2020 | 526 | 0.530 |
Why?
|
Colonic Neoplasms | 5 | 2011 | 2541 | 0.520 |
Why?
|
Vitamin D | 4 | 2016 | 3223 | 0.520 |
Why?
|
Risk | 16 | 2023 | 9687 | 0.510 |
Why?
|
Aged | 80 | 2024 | 163280 | 0.500 |
Why?
|
Methionine | 3 | 2014 | 590 | 0.500 |
Why?
|
Sweetening Agents | 2 | 2019 | 296 | 0.500 |
Why?
|
Resilience, Psychological | 1 | 2021 | 676 | 0.490 |
Why?
|
Communicable Disease Control | 2 | 2020 | 857 | 0.480 |
Why?
|
Growth Hormone | 2 | 2007 | 705 | 0.480 |
Why?
|
Feeding Behavior | 4 | 2023 | 3188 | 0.480 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2020 | 4034 | 0.470 |
Why?
|
Incidence | 29 | 2022 | 20947 | 0.470 |
Why?
|
Pregnancy | 14 | 2023 | 29144 | 0.460 |
Why?
|
Stress, Psychological | 6 | 2019 | 4245 | 0.460 |
Why?
|
Body Mass Index | 26 | 2021 | 12720 | 0.460 |
Why?
|
Denmark | 11 | 2015 | 738 | 0.450 |
Why?
|
United States | 40 | 2023 | 69872 | 0.450 |
Why?
|
Dermatitis, Atopic | 1 | 2020 | 654 | 0.450 |
Why?
|
Skin Neoplasms | 3 | 2020 | 5686 | 0.430 |
Why?
|
Male | 85 | 2024 | 350118 | 0.430 |
Why?
|
Cross-Sectional Studies | 26 | 2023 | 25043 | 0.430 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3133 | 0.420 |
Why?
|
Logistic Models | 17 | 2020 | 13408 | 0.420 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 8 | 2011 | 2282 | 0.420 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3240 | 0.420 |
Why?
|
Personnel Staffing and Scheduling | 3 | 2016 | 501 | 0.410 |
Why?
|
Somatomedins | 3 | 2007 | 192 | 0.410 |
Why?
|
Age Factors | 17 | 2020 | 18370 | 0.410 |
Why?
|
Adolescent Development | 1 | 2015 | 278 | 0.410 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 3 | 2007 | 123 | 0.410 |
Why?
|
Disorders of Excessive Somnolence | 2 | 2022 | 271 | 0.400 |
Why?
|
Gout Suppressants | 1 | 2013 | 166 | 0.400 |
Why?
|
Hot Flashes | 1 | 2014 | 317 | 0.400 |
Why?
|
Disease | 1 | 2017 | 680 | 0.400 |
Why?
|
Optical Devices | 1 | 2011 | 37 | 0.390 |
Why?
|
Carbonated Beverages | 1 | 2012 | 214 | 0.390 |
Why?
|
Research | 1 | 2020 | 1999 | 0.390 |
Why?
|
Diagnostic Tests, Routine | 1 | 2017 | 783 | 0.390 |
Why?
|
Physicians | 3 | 2023 | 4567 | 0.390 |
Why?
|
Influenza, Human | 1 | 2022 | 1479 | 0.380 |
Why?
|
CpG Islands | 3 | 2012 | 1172 | 0.370 |
Why?
|
Endometrial Neoplasms | 3 | 2008 | 1353 | 0.370 |
Why?
|
Cholecystectomy | 2 | 2003 | 395 | 0.370 |
Why?
|
Ethanol | 2 | 2014 | 1342 | 0.370 |
Why?
|
Menstrual Cycle | 4 | 2019 | 551 | 0.360 |
Why?
|
Birth Weight | 1 | 2018 | 2069 | 0.360 |
Why?
|
Adenoma | 5 | 2017 | 2174 | 0.360 |
Why?
|
Energy Intake | 2 | 2014 | 2148 | 0.350 |
Why?
|
Aspartame | 2 | 2023 | 18 | 0.340 |
Why?
|
Diabetes Mellitus, Type 2 | 10 | 2023 | 11725 | 0.340 |
Why?
|
DNA Methylation | 8 | 2014 | 4286 | 0.340 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2019 | 1414 | 0.340 |
Why?
|
Pancreatic Neoplasms | 6 | 2007 | 5256 | 0.330 |
Why?
|
Multivariate Analysis | 13 | 2019 | 12245 | 0.330 |
Why?
|
Antihypertensive Agents | 4 | 2022 | 2046 | 0.320 |
Why?
|
Risk Assessment | 25 | 2020 | 23338 | 0.320 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 3 | 2007 | 216 | 0.320 |
Why?
|
Young Adult | 18 | 2022 | 56430 | 0.320 |
Why?
|
Diabetes Mellitus | 4 | 2023 | 5751 | 0.320 |
Why?
|
Anxiety | 2 | 2020 | 4297 | 0.310 |
Why?
|
Work | 3 | 2015 | 191 | 0.310 |
Why?
|
Aging | 9 | 2021 | 8664 | 0.310 |
Why?
|
Neoplasms, Glandular and Epithelial | 3 | 2016 | 484 | 0.300 |
Why?
|
Endometriosis | 2 | 2015 | 839 | 0.300 |
Why?
|
Epirubicin | 3 | 1995 | 80 | 0.290 |
Why?
|
Follow-Up Studies | 21 | 2022 | 39050 | 0.290 |
Why?
|
Ovarian Neoplasms | 8 | 2020 | 4838 | 0.280 |
Why?
|
Human Development | 1 | 2007 | 124 | 0.280 |
Why?
|
Asthma | 2 | 2020 | 6011 | 0.280 |
Why?
|
Cognition Disorders | 4 | 2019 | 4043 | 0.280 |
Why?
|
Meat | 1 | 2009 | 592 | 0.280 |
Why?
|
Kidney Calculi | 2 | 2021 | 465 | 0.280 |
Why?
|
Gout | 1 | 2013 | 573 | 0.270 |
Why?
|
Affect | 1 | 2014 | 1476 | 0.270 |
Why?
|
Free Radical Scavengers | 1 | 2007 | 216 | 0.270 |
Why?
|
Longitudinal Studies | 9 | 2023 | 13989 | 0.270 |
Why?
|
Wrist Injuries | 1 | 2008 | 208 | 0.270 |
Why?
|
Genes, ras | 1 | 2008 | 690 | 0.270 |
Why?
|
Melanoma | 2 | 2016 | 5510 | 0.260 |
Why?
|
Complementary Therapies | 1 | 2009 | 486 | 0.260 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 2008 | 386 | 0.260 |
Why?
|
Occupations | 3 | 2023 | 517 | 0.260 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2012 | 1381 | 0.250 |
Why?
|
Workplace | 1 | 2011 | 836 | 0.250 |
Why?
|
Nursing | 1 | 2004 | 40 | 0.250 |
Why?
|
Health Personnel | 3 | 2023 | 3218 | 0.250 |
Why?
|
Aircraft | 1 | 2005 | 123 | 0.250 |
Why?
|
Gonadal Steroid Hormones | 2 | 2006 | 712 | 0.250 |
Why?
|
Multiple Sclerosis | 1 | 2019 | 3079 | 0.250 |
Why?
|
Reproduction | 2 | 2019 | 668 | 0.240 |
Why?
|
Epigenesis, Genetic | 3 | 2014 | 3647 | 0.240 |
Why?
|
Vitamin D Deficiency | 1 | 2014 | 1343 | 0.240 |
Why?
|
Leukemia | 1 | 2012 | 1511 | 0.240 |
Why?
|
Aged, 80 and over | 28 | 2020 | 57776 | 0.240 |
Why?
|
Polymorphism, Genetic | 2 | 2006 | 4328 | 0.240 |
Why?
|
Cyclin D1 | 1 | 2006 | 463 | 0.240 |
Why?
|
Antioxidants | 1 | 2012 | 1663 | 0.230 |
Why?
|
Eugenol | 1 | 2023 | 10 | 0.230 |
Why?
|
Pregnancy Proteins | 1 | 2005 | 229 | 0.230 |
Why?
|
Homocysteine | 1 | 2007 | 647 | 0.230 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 3 | 2017 | 1114 | 0.230 |
Why?
|
Creatinine | 5 | 2020 | 1919 | 0.230 |
Why?
|
Aspirin | 6 | 2011 | 3282 | 0.230 |
Why?
|
Drug Prescriptions | 1 | 2013 | 1637 | 0.230 |
Why?
|
Quality of Life | 4 | 2023 | 12804 | 0.230 |
Why?
|
Estrone | 1 | 2004 | 240 | 0.230 |
Why?
|
Attitude to Health | 2 | 2009 | 2052 | 0.220 |
Why?
|
Eczema | 2 | 2020 | 231 | 0.220 |
Why?
|
Testosterone | 1 | 2013 | 2420 | 0.210 |
Why?
|
Estradiol | 4 | 2013 | 2020 | 0.210 |
Why?
|
Snoring | 3 | 2022 | 191 | 0.210 |
Why?
|
Menstruation Disturbances | 2 | 2015 | 148 | 0.210 |
Why?
|
Health Behavior | 3 | 2015 | 2636 | 0.210 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2011 | 2043 | 0.210 |
Why?
|
Finland | 1 | 2023 | 602 | 0.200 |
Why?
|
Sex Factors | 10 | 2019 | 10397 | 0.200 |
Why?
|
Dentists | 1 | 2023 | 169 | 0.200 |
Why?
|
Biological Clocks | 1 | 2024 | 321 | 0.200 |
Why?
|
Digestive System Neoplasms | 1 | 2021 | 87 | 0.200 |
Why?
|
Inflammation | 2 | 2019 | 10638 | 0.200 |
Why?
|
Dehydroepiandrosterone | 2 | 2017 | 252 | 0.200 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2022 | 314 | 0.200 |
Why?
|
Adolescent | 13 | 2022 | 85781 | 0.190 |
Why?
|
Government | 1 | 2022 | 165 | 0.190 |
Why?
|
Fractures, Bone | 2 | 2014 | 1947 | 0.190 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2003 | 371 | 0.190 |
Why?
|
Pharmacists | 1 | 2023 | 248 | 0.190 |
Why?
|
Urban Health | 1 | 2023 | 547 | 0.190 |
Why?
|
Cholelithiasis | 1 | 2002 | 414 | 0.190 |
Why?
|
Mycotoxins | 1 | 2020 | 36 | 0.190 |
Why?
|
Olfaction Disorders | 1 | 2023 | 222 | 0.180 |
Why?
|
Leishmaniasis, Visceral | 1 | 2021 | 94 | 0.180 |
Why?
|
Waist-Hip Ratio | 2 | 2015 | 517 | 0.180 |
Why?
|
Congresses as Topic | 2 | 2021 | 764 | 0.180 |
Why?
|
Vitamin A | 1 | 2003 | 615 | 0.180 |
Why?
|
Hydrocortisone | 2 | 2019 | 1826 | 0.180 |
Why?
|
Caffeine | 2 | 2015 | 699 | 0.180 |
Why?
|
Registries | 11 | 2022 | 8089 | 0.180 |
Why?
|
Infectious Disease Medicine | 1 | 2020 | 46 | 0.180 |
Why?
|
Beverages | 1 | 2005 | 820 | 0.180 |
Why?
|
Child | 11 | 2023 | 77709 | 0.180 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2019 | 9239 | 0.180 |
Why?
|
Overweight | 3 | 2020 | 2371 | 0.170 |
Why?
|
alpha-Amylases | 1 | 2019 | 41 | 0.170 |
Why?
|
Knowledge | 1 | 2021 | 181 | 0.170 |
Why?
|
Prevalence | 10 | 2023 | 15226 | 0.170 |
Why?
|
Vaccination | 2 | 2022 | 3278 | 0.170 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2020 | 236 | 0.170 |
Why?
|
Coronary Artery Disease | 2 | 2016 | 6487 | 0.170 |
Why?
|
Steroids | 1 | 2004 | 930 | 0.170 |
Why?
|
Dogs | 1 | 2024 | 3912 | 0.170 |
Why?
|
Intergenerational Relations | 1 | 2019 | 68 | 0.170 |
Why?
|
Adolescent Behavior | 1 | 2007 | 1151 | 0.160 |
Why?
|
Hypersensitivity | 1 | 2007 | 1102 | 0.160 |
Why?
|
Nutritional Status | 1 | 2007 | 1609 | 0.160 |
Why?
|
Physicians, Women | 1 | 2004 | 486 | 0.160 |
Why?
|
Hip Fractures | 2 | 2022 | 955 | 0.160 |
Why?
|
Science | 1 | 2021 | 241 | 0.160 |
Why?
|
Social Responsibility | 1 | 2021 | 389 | 0.160 |
Why?
|
A Kinase Anchor Proteins | 1 | 2018 | 51 | 0.160 |
Why?
|
Research Report | 1 | 2021 | 355 | 0.160 |
Why?
|
Isoenzymes | 1 | 2003 | 1726 | 0.160 |
Why?
|
Health Surveys | 6 | 2019 | 4037 | 0.160 |
Why?
|
Arylalkylamine N-Acetyltransferase | 1 | 2017 | 12 | 0.160 |
Why?
|
Cause of Death | 4 | 2021 | 3584 | 0.150 |
Why?
|
Saliva | 2 | 2019 | 809 | 0.150 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2023 | 489 | 0.150 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2008 | 2948 | 0.150 |
Why?
|
Students | 1 | 2007 | 1654 | 0.150 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2019 | 563 | 0.150 |
Why?
|
Cultural Diversity | 1 | 2021 | 359 | 0.150 |
Why?
|
Lung Neoplasms | 5 | 2020 | 13102 | 0.150 |
Why?
|
Pre-Eclampsia | 2 | 2023 | 1200 | 0.150 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2018 | 199 | 0.150 |
Why?
|
Renal Replacement Therapy | 1 | 2019 | 257 | 0.150 |
Why?
|
Mortality | 4 | 2022 | 2864 | 0.150 |
Why?
|
Carcinoma | 1 | 2008 | 2375 | 0.150 |
Why?
|
Preconception Care | 1 | 2018 | 134 | 0.140 |
Why?
|
Nerve Tissue Proteins | 3 | 2017 | 4462 | 0.140 |
Why?
|
Anti-Mullerian Hormone | 1 | 2019 | 402 | 0.140 |
Why?
|
Genetic Predisposition to Disease | 7 | 2018 | 17446 | 0.140 |
Why?
|
Biological Specimen Banks | 2 | 2021 | 711 | 0.140 |
Why?
|
Health Policy | 2 | 2021 | 2661 | 0.140 |
Why?
|
Urothelium | 1 | 2018 | 277 | 0.140 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2020 | 378 | 0.140 |
Why?
|
Epidemiologic Studies | 1 | 2020 | 676 | 0.140 |
Why?
|
Walking | 1 | 2024 | 1180 | 0.140 |
Why?
|
Polymorphism, Single Nucleotide | 7 | 2021 | 15519 | 0.140 |
Why?
|
Animals | 14 | 2024 | 168757 | 0.140 |
Why?
|
Parturition | 1 | 2020 | 441 | 0.140 |
Why?
|
Population Surveillance | 3 | 2021 | 2616 | 0.130 |
Why?
|
Respiratory Tract Diseases | 1 | 2021 | 722 | 0.130 |
Why?
|
Mendelian Randomization Analysis | 1 | 2021 | 967 | 0.130 |
Why?
|
Interviews as Topic | 2 | 2015 | 2539 | 0.130 |
Why?
|
Sleep Apnea, Obstructive | 2 | 2021 | 1813 | 0.130 |
Why?
|
Chronic Disease | 4 | 2023 | 9146 | 0.130 |
Why?
|
Quinine | 1 | 1995 | 54 | 0.130 |
Why?
|
Communicable Diseases, Emerging | 1 | 2017 | 157 | 0.130 |
Why?
|
Erythrocytes | 2 | 1995 | 2455 | 0.130 |
Why?
|
Pregnancy Trimester, Second | 1 | 2018 | 732 | 0.130 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2010 | 3923 | 0.130 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2016 | 314 | 0.130 |
Why?
|
Spinal Fractures | 1 | 2022 | 696 | 0.130 |
Why?
|
Estrogens | 1 | 2002 | 1566 | 0.130 |
Why?
|
Lifting | 1 | 2015 | 56 | 0.130 |
Why?
|
Residence Characteristics | 2 | 2015 | 2050 | 0.130 |
Why?
|
Carcinogens, Environmental | 1 | 2015 | 67 | 0.130 |
Why?
|
Adenocarcinoma, Clear Cell | 1 | 2016 | 221 | 0.130 |
Why?
|
Blindness | 2 | 2009 | 617 | 0.130 |
Why?
|
Chronotherapy | 3 | 2022 | 10 | 0.120 |
Why?
|
Creatine | 1 | 2016 | 421 | 0.120 |
Why?
|
Multiple Myeloma | 1 | 2012 | 5181 | 0.120 |
Why?
|
Women's Health | 3 | 2020 | 2034 | 0.120 |
Why?
|
Genotype | 6 | 2018 | 12951 | 0.120 |
Why?
|
Age of Onset | 2 | 2019 | 3271 | 0.120 |
Why?
|
International Agencies | 1 | 2015 | 240 | 0.120 |
Why?
|
Drug Resistance, Multiple | 1 | 1995 | 252 | 0.120 |
Why?
|
Ovary | 1 | 2019 | 981 | 0.120 |
Why?
|
Interprofessional Relations | 1 | 2020 | 1011 | 0.120 |
Why?
|
Self Report | 4 | 2022 | 3558 | 0.120 |
Why?
|
Microsatellite Instability | 4 | 2012 | 684 | 0.120 |
Why?
|
Interferon-alpha | 2 | 1995 | 895 | 0.120 |
Why?
|
Prostatic Neoplasms | 6 | 2017 | 11124 | 0.120 |
Why?
|
DNA, Neoplasm | 2 | 2009 | 1758 | 0.120 |
Why?
|
Benchmarking | 1 | 2020 | 1042 | 0.110 |
Why?
|
Alzheimer Disease | 3 | 2023 | 8037 | 0.110 |
Why?
|
Socioeconomic Factors | 2 | 2019 | 7785 | 0.110 |
Why?
|
Fertility | 2 | 2015 | 781 | 0.110 |
Why?
|
Carcinoma, Papillary | 1 | 2018 | 783 | 0.110 |
Why?
|
Linear Models | 5 | 2019 | 5952 | 0.110 |
Why?
|
Diet, Mediterranean | 1 | 2020 | 700 | 0.110 |
Why?
|
Schools | 1 | 2022 | 1433 | 0.110 |
Why?
|
Weight Gain | 3 | 2024 | 2292 | 0.110 |
Why?
|
Epidemiologic Methods | 3 | 2010 | 1364 | 0.110 |
Why?
|
Epidemiologic Research Design | 1 | 2016 | 367 | 0.110 |
Why?
|
Publications | 1 | 2015 | 195 | 0.110 |
Why?
|
Public Health | 3 | 2021 | 2603 | 0.100 |
Why?
|
Communicable Diseases | 1 | 2021 | 880 | 0.100 |
Why?
|
Health Services Needs and Demand | 1 | 2020 | 1411 | 0.100 |
Why?
|
Hypercholesterolemia | 1 | 2019 | 1151 | 0.100 |
Why?
|
Body Weight | 2 | 2020 | 4669 | 0.100 |
Why?
|
Burnout, Professional | 1 | 2020 | 694 | 0.100 |
Why?
|
Polysomnography | 2 | 2016 | 1776 | 0.100 |
Why?
|
Calcium Channels, T-Type | 1 | 2011 | 34 | 0.100 |
Why?
|
Early Detection of Cancer | 2 | 2023 | 3086 | 0.100 |
Why?
|
Comorbidity | 6 | 2020 | 10388 | 0.100 |
Why?
|
Core Binding Factor Alpha 3 Subunit | 1 | 2011 | 56 | 0.100 |
Why?
|
Maternal Exposure | 1 | 2018 | 961 | 0.100 |
Why?
|
Nursing Staff, Hospital | 1 | 2015 | 346 | 0.100 |
Why?
|
Health Promotion | 1 | 2003 | 2205 | 0.100 |
Why?
|
Antibiotics, Antineoplastic | 1 | 1995 | 692 | 0.100 |
Why?
|
Nursing Staff | 1 | 2012 | 129 | 0.100 |
Why?
|
Spouses | 1 | 2014 | 286 | 0.100 |
Why?
|
Actigraphy | 1 | 2015 | 488 | 0.100 |
Why?
|
Europe | 3 | 2023 | 3339 | 0.100 |
Why?
|
Calcium Channel Blockers | 2 | 2010 | 690 | 0.100 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 3870 | 0.100 |
Why?
|
Adaptation, Psychological | 1 | 2021 | 2576 | 0.100 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2015 | 713 | 0.090 |
Why?
|
Receptors, Retinoic Acid | 1 | 2011 | 232 | 0.090 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2011 | 175 | 0.090 |
Why?
|
Hair Color | 1 | 2011 | 136 | 0.090 |
Why?
|
Dihydropyridines | 1 | 2010 | 67 | 0.090 |
Why?
|
Epidemiology | 1 | 2013 | 287 | 0.090 |
Why?
|
Amlodipine | 1 | 2010 | 83 | 0.090 |
Why?
|
Family Health | 1 | 2015 | 1282 | 0.090 |
Why?
|
Double-Blind Method | 3 | 2014 | 12026 | 0.090 |
Why?
|
Renal Dialysis | 1 | 2019 | 1786 | 0.090 |
Why?
|
Pathology, Molecular | 1 | 2013 | 326 | 0.090 |
Why?
|
Medical Records | 1 | 2015 | 1413 | 0.090 |
Why?
|
Radioimmunoassay | 1 | 2010 | 919 | 0.090 |
Why?
|
Patient Care Team | 1 | 2020 | 2531 | 0.080 |
Why?
|
Infertility, Female | 1 | 2015 | 787 | 0.080 |
Why?
|
Workload | 1 | 2015 | 850 | 0.080 |
Why?
|
Sensitivity and Specificity | 3 | 2022 | 14722 | 0.080 |
Why?
|
Vitamin B 6 Deficiency | 1 | 2008 | 17 | 0.080 |
Why?
|
Progesterone | 1 | 2013 | 776 | 0.080 |
Why?
|
Pregnancy Outcome | 1 | 2019 | 2795 | 0.080 |
Why?
|
Aromatase | 1 | 2008 | 146 | 0.080 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2011 | 504 | 0.080 |
Why?
|
Polymerase Chain Reaction | 2 | 2011 | 6171 | 0.080 |
Why?
|
Caregivers | 2 | 2014 | 2094 | 0.080 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2011 | 705 | 0.080 |
Why?
|
Disease Outbreaks | 1 | 2017 | 1772 | 0.080 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2018 | 6038 | 0.080 |
Why?
|
Research Design | 4 | 2011 | 5987 | 0.080 |
Why?
|
Blood Cells | 1 | 2010 | 309 | 0.080 |
Why?
|
Climacteric | 1 | 2007 | 57 | 0.080 |
Why?
|
Predictive Value of Tests | 3 | 2017 | 15076 | 0.080 |
Why?
|
Electroencephalography | 1 | 2023 | 6150 | 0.080 |
Why?
|
Genome-Wide Association Study | 3 | 2021 | 12261 | 0.080 |
Why?
|
Folic Acid Deficiency | 1 | 2008 | 115 | 0.080 |
Why?
|
Reproducibility of Results | 5 | 2020 | 19905 | 0.080 |
Why?
|
Colon | 2 | 2019 | 1772 | 0.070 |
Why?
|
Sex Characteristics | 2 | 2020 | 2585 | 0.070 |
Why?
|
Tryptophan | 1 | 2009 | 478 | 0.070 |
Why?
|
Epigenomics | 1 | 2013 | 903 | 0.070 |
Why?
|
Los Angeles | 1 | 2007 | 238 | 0.070 |
Why?
|
Uric Acid | 1 | 2013 | 766 | 0.070 |
Why?
|
Educational Status | 1 | 2015 | 2540 | 0.070 |
Why?
|
Disease Progression | 3 | 2019 | 13284 | 0.070 |
Why?
|
Physical Fitness | 2 | 2016 | 733 | 0.070 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2020 | 2208 | 0.070 |
Why?
|
Menarche | 1 | 2009 | 516 | 0.070 |
Why?
|
Kidney Failure, Chronic | 1 | 2019 | 2538 | 0.070 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6895 | 0.070 |
Why?
|
Education | 1 | 2009 | 543 | 0.070 |
Why?
|
Antidepressive Agents | 1 | 2018 | 2838 | 0.070 |
Why?
|
Administration, Oral | 2 | 2012 | 3913 | 0.070 |
Why?
|
Chromatography, Liquid | 2 | 2020 | 976 | 0.070 |
Why?
|
Time | 1 | 2007 | 542 | 0.070 |
Why?
|
Dementia | 1 | 2020 | 2518 | 0.070 |
Why?
|
Health Status | 1 | 2019 | 4034 | 0.070 |
Why?
|
Genes, p53 | 1 | 2008 | 755 | 0.070 |
Why?
|
Death, Sudden, Cardiac | 1 | 2014 | 1541 | 0.070 |
Why?
|
Social Support | 2 | 2006 | 2118 | 0.070 |
Why?
|
Vitamins | 1 | 2014 | 1622 | 0.070 |
Why?
|
Receptors, Estrogen | 1 | 2013 | 2187 | 0.060 |
Why?
|
Telomere | 1 | 2011 | 910 | 0.060 |
Why?
|
Life Change Events | 1 | 2010 | 938 | 0.060 |
Why?
|
Cerebral Infarction | 1 | 2010 | 1011 | 0.060 |
Why?
|
Alleles | 2 | 2015 | 6933 | 0.060 |
Why?
|
Androstenols | 1 | 2004 | 25 | 0.060 |
Why?
|
Estrogen Receptor alpha | 1 | 2008 | 577 | 0.060 |
Why?
|
Sexual Harassment | 1 | 2005 | 79 | 0.060 |
Why?
|
Coronary Disease | 1 | 2019 | 6077 | 0.060 |
Why?
|
Intracranial Hemorrhages | 1 | 2010 | 855 | 0.060 |
Why?
|
Androstenedione | 1 | 2004 | 131 | 0.060 |
Why?
|
Psoriasis | 1 | 2012 | 898 | 0.060 |
Why?
|
Osteoporosis | 1 | 2014 | 1580 | 0.060 |
Why?
|
Serotonin | 1 | 2008 | 1017 | 0.060 |
Why?
|
Darkness | 1 | 2004 | 167 | 0.060 |
Why?
|
Amitriptyline | 1 | 2004 | 110 | 0.060 |
Why?
|
Ulnar Nerve | 1 | 2004 | 106 | 0.060 |
Why?
|
Myocardial Infarction | 2 | 2016 | 11727 | 0.060 |
Why?
|
Confidence Intervals | 2 | 2011 | 2971 | 0.060 |
Why?
|
Publication Bias | 1 | 2004 | 162 | 0.060 |
Why?
|
Acetaminophen | 1 | 2008 | 545 | 0.060 |
Why?
|
Nutrition Surveys | 2 | 2021 | 1660 | 0.060 |
Why?
|
Carcinogenicity Tests | 1 | 2023 | 41 | 0.060 |
Why?
|
Iceland | 2 | 2014 | 183 | 0.060 |
Why?
|
Kidney Neoplasms | 1 | 2020 | 4262 | 0.060 |
Why?
|
Survivors | 1 | 2014 | 2291 | 0.060 |
Why?
|
Biological Availability | 1 | 2004 | 397 | 0.060 |
Why?
|
Respiratory Sounds | 1 | 2007 | 696 | 0.060 |
Why?
|
Organoplatinum Compounds | 1 | 2005 | 408 | 0.060 |
Why?
|
Cattle | 1 | 2009 | 3922 | 0.060 |
Why?
|
Genetic Association Studies | 3 | 2018 | 2703 | 0.060 |
Why?
|
Immunohistochemistry | 3 | 2019 | 11366 | 0.060 |
Why?
|
Social Isolation | 1 | 2006 | 365 | 0.060 |
Why?
|
Environmental Exposure | 1 | 2017 | 4234 | 0.050 |
Why?
|
Nucleoproteins | 1 | 2023 | 115 | 0.050 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2003 | 768 | 0.050 |
Why?
|
Retrospective Studies | 9 | 2023 | 77449 | 0.050 |
Why?
|
Treatment Outcome | 3 | 2019 | 63114 | 0.050 |
Why?
|
Infant, Newborn | 2 | 2020 | 25625 | 0.050 |
Why?
|
Algorithms | 1 | 2023 | 13881 | 0.050 |
Why?
|
Skin Temperature | 1 | 2022 | 93 | 0.050 |
Why?
|
Secretory Rate | 1 | 2001 | 82 | 0.050 |
Why?
|
Prolactin | 1 | 2004 | 669 | 0.050 |
Why?
|
Survival Analysis | 4 | 2012 | 10252 | 0.050 |
Why?
|
Morbidity | 1 | 2007 | 1769 | 0.050 |
Why?
|
Health Care Surveys | 1 | 2009 | 2453 | 0.050 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 329 | 0.050 |
Why?
|
Colitis, Ulcerative | 1 | 2014 | 1912 | 0.050 |
Why?
|
Estrogen Replacement Therapy | 1 | 2008 | 1203 | 0.050 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2011 | 1861 | 0.050 |
Why?
|
Blood Pressure | 3 | 2022 | 8554 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2015 | 5021 | 0.050 |
Why?
|
Antibodies, Viral | 2 | 2023 | 3176 | 0.050 |
Why?
|
Sequence Analysis, DNA | 2 | 2010 | 4803 | 0.050 |
Why?
|
Seroepidemiologic Studies | 1 | 2023 | 401 | 0.050 |
Why?
|
Insulin Resistance | 2 | 2013 | 3864 | 0.050 |
Why?
|
Dietary Supplements | 1 | 2014 | 3297 | 0.050 |
Why?
|
Cross-Cultural Comparison | 1 | 2004 | 651 | 0.050 |
Why?
|
Body Temperature Regulation | 1 | 2022 | 252 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2008 | 2942 | 0.050 |
Why?
|
Smell | 1 | 2023 | 244 | 0.050 |
Why?
|
Prejudice | 1 | 2005 | 570 | 0.050 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2003 | 320 | 0.050 |
Why?
|
Infant | 2 | 2020 | 35136 | 0.050 |
Why?
|
Visual Perception | 1 | 2009 | 1420 | 0.050 |
Why?
|
France | 1 | 2022 | 517 | 0.050 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2011 | 2916 | 0.050 |
Why?
|
Cyclooxygenase 2 | 1 | 2003 | 611 | 0.050 |
Why?
|
Lipid Metabolism | 1 | 2008 | 1889 | 0.050 |
Why?
|
Mass Vaccination | 1 | 2021 | 105 | 0.050 |
Why?
|
Italy | 1 | 2022 | 832 | 0.040 |
Why?
|
Evidence-Based Medicine | 1 | 2012 | 3610 | 0.040 |
Why?
|
Genetic Variation | 1 | 2015 | 6544 | 0.040 |
Why?
|
Cell Cycle Proteins | 1 | 2011 | 3462 | 0.040 |
Why?
|
Signal Transduction | 3 | 2019 | 23403 | 0.040 |
Why?
|
Cell Division | 2 | 2004 | 4568 | 0.040 |
Why?
|
Pregnancy Trimester, First | 1 | 2023 | 853 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2008 | 3920 | 0.040 |
Why?
|
Specimen Handling | 1 | 2004 | 694 | 0.040 |
Why?
|
Thyroid Hormones | 1 | 2022 | 390 | 0.040 |
Why?
|
Sex Distribution | 1 | 2004 | 2297 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2020 | 8863 | 0.040 |
Why?
|
Body Temperature | 1 | 2022 | 777 | 0.040 |
Why?
|
Sleep Deprivation | 1 | 2006 | 832 | 0.040 |
Why?
|
Circadian Clocks | 1 | 2021 | 171 | 0.040 |
Why?
|
Stroke | 2 | 2014 | 9981 | 0.040 |
Why?
|
Colonoscopy | 2 | 2023 | 1367 | 0.040 |
Why?
|
Food Contamination | 1 | 2020 | 188 | 0.040 |
Why?
|
Child, Preschool | 2 | 2018 | 41006 | 0.040 |
Why?
|
Neoplasm Proteins | 1 | 2011 | 3703 | 0.040 |
Why?
|
Ferritins | 1 | 2021 | 590 | 0.040 |
Why?
|
Intestinal Mucosa | 1 | 2010 | 3036 | 0.040 |
Why?
|
Mood Disorders | 1 | 2005 | 1106 | 0.040 |
Why?
|
Universities | 1 | 2003 | 956 | 0.040 |
Why?
|
Down-Regulation | 2 | 2016 | 3002 | 0.040 |
Why?
|
Delphi Technique | 1 | 2020 | 778 | 0.040 |
Why?
|
Nerve Block | 1 | 2004 | 644 | 0.040 |
Why?
|
Autoimmune Diseases | 1 | 2009 | 2133 | 0.040 |
Why?
|
Drug Utilization | 1 | 2004 | 1183 | 0.040 |
Why?
|
Exercise | 2 | 2021 | 5615 | 0.040 |
Why?
|
Molecular Epidemiology | 1 | 2019 | 468 | 0.040 |
Why?
|
Software Design | 1 | 2017 | 176 | 0.040 |
Why?
|
Zinc | 1 | 2021 | 684 | 0.040 |
Why?
|
Semantics | 1 | 2020 | 584 | 0.040 |
Why?
|
Glomerulonephritis | 1 | 2019 | 372 | 0.040 |
Why?
|
Patient Satisfaction | 1 | 2009 | 3396 | 0.040 |
Why?
|
Brazil | 1 | 2021 | 1270 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2001 | 1677 | 0.040 |
Why?
|
BCG Vaccine | 1 | 2019 | 369 | 0.030 |
Why?
|
Fibrinogen | 1 | 2019 | 894 | 0.030 |
Why?
|
Nuclear Proteins | 1 | 2011 | 5853 | 0.030 |
Why?
|
Drug Approval | 1 | 2003 | 742 | 0.030 |
Why?
|
Metabolome | 1 | 2023 | 895 | 0.030 |
Why?
|
Independent Living | 1 | 2020 | 568 | 0.030 |
Why?
|
Temperature | 1 | 2022 | 2206 | 0.030 |
Why?
|
Genomic Instability | 2 | 2010 | 695 | 0.030 |
Why?
|
Prostate-Specific Antigen | 1 | 2005 | 2494 | 0.030 |
Why?
|
Information Systems | 1 | 2017 | 410 | 0.030 |
Why?
|
Academies and Institutes | 1 | 2017 | 317 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2010 | 3255 | 0.030 |
Why?
|
Data Collection | 1 | 2004 | 3341 | 0.030 |
Why?
|
Metabolic Clearance Rate | 1 | 1995 | 380 | 0.030 |
Why?
|
Epidemics | 1 | 2021 | 523 | 0.030 |
Why?
|
Rectum | 1 | 2019 | 904 | 0.030 |
Why?
|
Environment | 1 | 2021 | 1124 | 0.030 |
Why?
|
Verapamil | 1 | 1995 | 244 | 0.030 |
Why?
|
Models, Biological | 3 | 2021 | 9583 | 0.030 |
Why?
|
International Cooperation | 1 | 2020 | 1420 | 0.030 |
Why?
|
Tandem Mass Spectrometry | 1 | 2020 | 1157 | 0.030 |
Why?
|
Pituitary-Adrenal System | 1 | 2017 | 553 | 0.030 |
Why?
|
Adiposity | 1 | 2024 | 1807 | 0.030 |
Why?
|
Regression Analysis | 3 | 2013 | 6459 | 0.030 |
Why?
|
Half-Life | 1 | 1995 | 661 | 0.030 |
Why?
|
Neuropsychological Tests | 2 | 2023 | 6993 | 0.030 |
Why?
|
Eating | 1 | 2020 | 1536 | 0.030 |
Why?
|
Drug Interactions | 2 | 1995 | 1460 | 0.030 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2017 | 703 | 0.030 |
Why?
|
Prescription Drugs | 2 | 2010 | 595 | 0.030 |
Why?
|
Urban Population | 1 | 2021 | 2021 | 0.030 |
Why?
|
Cholesterol, HDL | 1 | 2019 | 1814 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2020 | 2170 | 0.030 |
Why?
|
Depressive Disorder | 1 | 2005 | 3748 | 0.030 |
Why?
|
Prognosis | 5 | 2011 | 29063 | 0.030 |
Why?
|
Academic Medical Centers | 1 | 2023 | 2759 | 0.030 |
Why?
|
Age Distribution | 2 | 2010 | 2902 | 0.030 |
Why?
|
Climate Change | 1 | 2017 | 418 | 0.030 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1477 | 0.030 |
Why?
|
Breast Feeding | 1 | 2020 | 1338 | 0.030 |
Why?
|
Triglycerides | 1 | 2019 | 2454 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2021 | 3200 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2017 | 950 | 0.020 |
Why?
|
Consensus | 1 | 2020 | 2959 | 0.020 |
Why?
|
Organ Size | 1 | 2016 | 2252 | 0.020 |
Why?
|
Phenotype | 1 | 2008 | 16365 | 0.020 |
Why?
|
Rural Population | 1 | 2021 | 2210 | 0.020 |
Why?
|
Lip Neoplasms | 1 | 2010 | 37 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2022 | 4560 | 0.020 |
Why?
|
Cholesterol | 1 | 2019 | 2917 | 0.020 |
Why?
|
Biological Transport | 1 | 2015 | 2118 | 0.020 |
Why?
|
Fluorouracil | 1 | 1995 | 1619 | 0.020 |
Why?
|
Quantitative Trait Loci | 1 | 2018 | 2019 | 0.020 |
Why?
|
Cholesterol, LDL | 1 | 2019 | 2356 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2005 | 11524 | 0.020 |
Why?
|
Sulfites | 1 | 2010 | 79 | 0.020 |
Why?
|
Survival Rate | 3 | 2012 | 12788 | 0.020 |
Why?
|
Gene Frequency | 1 | 2016 | 3588 | 0.020 |
Why?
|
Mass Screening | 1 | 2005 | 5255 | 0.020 |
Why?
|
Community Health Planning | 1 | 2010 | 165 | 0.020 |
Why?
|
Mutation | 2 | 2011 | 29786 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 1995 | 2029 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2007 | 10943 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2021 | 3279 | 0.020 |
Why?
|
Medical History Taking | 1 | 2012 | 783 | 0.020 |
Why?
|
Substance-Related Disorders | 1 | 2005 | 4258 | 0.020 |
Why?
|
Sunlight | 1 | 2010 | 325 | 0.020 |
Why?
|
Recombinant Proteins | 2 | 1995 | 6622 | 0.020 |
Why?
|
Pilot Projects | 1 | 2021 | 8324 | 0.020 |
Why?
|
Lipids | 1 | 2019 | 3305 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2019 | 3778 | 0.020 |
Why?
|
Disease Susceptibility | 2 | 2005 | 1782 | 0.020 |
Why?
|
Drug Administration Schedule | 2 | 2007 | 4933 | 0.020 |
Why?
|
Communication | 1 | 2021 | 3749 | 0.020 |
Why?
|
Chronobiology Phenomena | 1 | 2006 | 30 | 0.020 |
Why?
|
Sample Size | 1 | 2009 | 845 | 0.020 |
Why?
|
Area Under Curve | 1 | 2010 | 1654 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2003 | 7880 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2009 | 1005 | 0.020 |
Why?
|
Causality | 1 | 2012 | 1275 | 0.020 |
Why?
|
Mental Status Schedule | 1 | 2006 | 321 | 0.020 |
Why?
|
Kidney | 1 | 2020 | 7186 | 0.020 |
Why?
|
Receptors, Somatomedin | 1 | 2004 | 57 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2011 | 1312 | 0.020 |
Why?
|
Community Networks | 1 | 2006 | 203 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2018 | 11031 | 0.010 |
Why?
|
Etoposide | 1 | 2005 | 641 | 0.010 |
Why?
|
ras Proteins | 1 | 2008 | 1060 | 0.010 |
Why?
|
Terminology as Topic | 1 | 2010 | 1547 | 0.010 |
Why?
|
Databases, Genetic | 1 | 2010 | 1783 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2016 | 2988 | 0.010 |
Why?
|
Erythema | 1 | 2004 | 257 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4751 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2009 | 3508 | 0.010 |
Why?
|
Protein Binding | 1 | 1995 | 9386 | 0.010 |
Why?
|
ROC Curve | 1 | 2010 | 3527 | 0.010 |
Why?
|
Outpatients | 1 | 2010 | 1486 | 0.010 |
Why?
|
Somatostatin | 1 | 2004 | 459 | 0.010 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2005 | 903 | 0.010 |
Why?
|
Social Class | 1 | 2010 | 1999 | 0.010 |
Why?
|
Coffee | 1 | 2006 | 578 | 0.010 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2008 | 1692 | 0.010 |
Why?
|
Autoantibodies | 1 | 2009 | 2035 | 0.010 |
Why?
|
Bupivacaine | 1 | 2004 | 411 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2016 | 8428 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2008 | 3616 | 0.010 |
Why?
|
Biomedical Research | 1 | 2015 | 3309 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2006 | 2373 | 0.010 |
Why?
|
Clinical Trials as Topic | 2 | 2005 | 7913 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 2716 | 0.010 |
Why?
|
Longevity | 1 | 2004 | 1070 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2008 | 4554 | 0.010 |
Why?
|
Databases, Factual | 1 | 2010 | 7729 | 0.010 |
Why?
|
Homeostasis | 1 | 2004 | 3340 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2004 | 2899 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 1995 | 2274 | 0.010 |
Why?
|
Brain | 1 | 2016 | 26385 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 35421 | 0.010 |
Why?
|
Pain | 1 | 2004 | 4986 | 0.010 |
Why?
|
Drug Resistance | 1 | 1995 | 1609 | 0.010 |
Why?
|
Apoptosis | 1 | 2004 | 9727 | 0.000 |
Why?
|
Mice | 1 | 2004 | 81183 | 0.000 |
Why?
|